Correlation Between C4 Therapeutics and Nuvation Bio
Can any of the company-specific risk be diversified away by investing in both C4 Therapeutics and Nuvation Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C4 Therapeutics and Nuvation Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between C4 Therapeutics and Nuvation Bio, you can compare the effects of market volatilities on C4 Therapeutics and Nuvation Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C4 Therapeutics with a short position of Nuvation Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of C4 Therapeutics and Nuvation Bio.
Diversification Opportunities for C4 Therapeutics and Nuvation Bio
0.12 | Correlation Coefficient |
Average diversification
The 3 months correlation between CCCC and Nuvation is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding C4 Therapeutics and Nuvation Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvation Bio and C4 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C4 Therapeutics are associated (or correlated) with Nuvation Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvation Bio has no effect on the direction of C4 Therapeutics i.e., C4 Therapeutics and Nuvation Bio go up and down completely randomly.
Pair Corralation between C4 Therapeutics and Nuvation Bio
Given the investment horizon of 90 days C4 Therapeutics is expected to generate 2.07 times more return on investment than Nuvation Bio. However, C4 Therapeutics is 2.07 times more volatile than Nuvation Bio. It trades about 0.04 of its potential returns per unit of risk. Nuvation Bio is currently generating about 0.05 per unit of risk. If you would invest 348.00 in C4 Therapeutics on September 1, 2024 and sell it today you would earn a total of 107.00 from holding C4 Therapeutics or generate 30.75% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
C4 Therapeutics vs. Nuvation Bio
Performance |
| Timeline |
| C4 Therapeutics |
| Nuvation Bio |
C4 Therapeutics and Nuvation Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with C4 Therapeutics and Nuvation Bio
The main advantage of trading using opposite C4 Therapeutics and Nuvation Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C4 Therapeutics position performs unexpectedly, Nuvation Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvation Bio will offset losses from the drop in Nuvation Bio's long position.| C4 Therapeutics vs. Shattuck Labs | C4 Therapeutics vs. Eliem Therapeutics | C4 Therapeutics vs. Prelude Therapeutics | C4 Therapeutics vs. Monte Rosa Therapeutics |
| Nuvation Bio vs. Cue Biopharma | Nuvation Bio vs. Tff Pharmaceuticals | Nuvation Bio vs. Lantern Pharma | Nuvation Bio vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |